Credit Agricole S A Y M Abs Therapeutics, Inc. Transaction History
Credit Agricole S A
- $33.2 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding YMAB
# of Institutions
112Shares Held
27MCall Options Held
5.6KPut Options Held
900-
Paradigm Biocapital Advisors LP New York, NY4.24MShares$17.5 Million1.27% of portfolio
-
Black Rock Inc. New York, NY2.94MShares$12.1 Million0.0% of portfolio
-
Acorn Capital Advisors, LLC New York, NY2.86MShares$11.8 Million12.11% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.19MShares$9.06 Million1.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA2MShares$8.26 Million0.0% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $181M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...